609th MEETING, LEEDS 77 would suggest that the enzyme responsible for mediumchain fatty acid activation is not active at this time. The lack of antagonism of salicylate and octanoate against the embryotoxic effects of valproate is also compatible with the mechanisms of teratogenicity and hepatotoxicity being fundamentally different. Although these data rule out one possibility, they provide little direct information on the actual biochemical mechanism of VPA teratogenicity. We are currently studying the actions of valproate on the synthesis of fatty acid and other components of embryonic cell membranes. These observations do provide a good example of metabolic differences between embryonic and adult tissues and emphasize the need for a greater understanding of intermediary metabolism in the mammalian organogenesis phase of development. Lastly, a thorough understanding of metabolism is a sine qua non for mechanistic interpretations of the effects of drugs o n embryos (see Brown et al., 1985). Despite the importance of acquiring data on mammalianembryo metabolism, it has only recently become possible to provide a quantitative description of energy metabolism for the first half of gestation in the mouse. Other species are less well served : data are available for preimplantation rat and rabbit embryos and for organogenesis-stage rat embryos. With the development of techniques for measuring such parameters of metabolism as substrate uptake and metabolite levels in single embryos from the earliest stages (e.g. Barbehenn et al., 1974; Spielmarin et al., 1981 ; Leese &Barton, 1984; Leese cr al., 1984), it will become possible to study metabolism in the embryos of monovular species such as ungulates and primates. In the meantime the mouse, and to a lesser extent the rat, must serve as our models for embryo metabolism during mammalian embryogenesis.
Mammalian embryos present two problems to the biochemist: small size and paucity of numbers. Inevitably this has restricted biochemical investigations to areas for which highly sensitive assay techniques art: available. Energy metabolism has received particular attention for a number of reasons. Firstly, useful quantitative information can be obtained readily for virtually all stage:; of development by using straightforward procedures. Its physiological roles and functioning are well understood. Its central position with respect to all biochemical processes means that it is a very sensitive indicator of biochemical changes or disturbances during development. Knowledge of the energy substrates that the embryo requires and their utilization can clarify aspects of the physiology of the maternal reproductive tract and assist in the development of culture techniques in iitro. Lastly, a thorough understanding of metabolism is a sine qua non for mechanistic interpretations of the effects of drugs o n embryos (see Brown et al., 1985) . Despite the importance of acquiring data on mammalianembryo metabolism, it has only recently become possible to provide a quantitative description of energy metabolism for the first half of gestation in the mouse. Other species are less well served : data are available for preimplantation rat and rabbit embryos and for organogenesis-stage rat embryos. With the development of techniques for measuring such parameters of metabolism as substrate uptake and metabolite levels in single embryos from the earliest stages (e.g. Barbehenn et al., 1974; Spielmarin et al., 1981 ; Leese &Barton, 1984; Leese cr al., 1984) , it will become possible to study metabolism in the embryos of monovular species such as ungulates and primates. In the meantime the mouse, and to a lesser extent the rat, must serve as our models for embryo metabolism during mammalian embryogenesis.
~r e i m~l a n t a t i o n embryo metabofism
Characteristically preimplantation development in mammals involves no growth; a number of cleavage divisions with long cell-cycle times (about 12h); and the formation of the blastocyst consisting of two cell types, trophectoderm and inner cell mass. In contrast to thc eggs of many nonmammalian species, the mouse egg is not metabolically activated at fertilization. Instead metabolic rates (e.g. O2 uptake, Mills & Brinster, 1967; protein synthesis, Brinster et al., 1976; and RNA synthesis, Clegg & Piko, 1977) increase gradually during the preimplantation period. This overall increase in metabolic rate is accompanied by increased glucose utilization.
Only oxaloacetate and pyruvate are capable of sustaining cleavage of the mouse zygote to the two-cell stage in oitro (Biggers et al., 1967) . Studies with radiolabelled substrates (reviewed by Biggers & Stern, 1973; Wales, 1975) have confirmed that throughout the first 2.5 days of development (i.e. until the eight-cell stage) pyruvate and lactate are both oxidized through the tricarboxylic acid cycle to yield C 0 2 at rates of about 7 and 3pmol/embryo per h, respectively. In contrast glucose, which is unable to support development in ritro until the eight-cell stage, only yields about 1 pmol of COJembryo per h at this time. Glucose can enter the embryo at the two-cell stage (Wales & Brinster, 1968) , can be readily phosphorylated (Barbehenn et al., 1974) and the embryo has substantial glycogen stores from the two-cell stage (Stern & Biggers, 1968) , but glucose cannot be used as a major source of energy because glycolysis is blocked at the phosphofructokinase step during early development (Barbehenn et d., 1974) . Maximal phosphofructokinase activity remains constant in the preimplantation embryo (Brinster, 1971) but metabolite concentrations, measured in single embryos by nucleotide-recycling methods, indicate that the block is maintained by the allosteric effects of high citrate (about 2mM) and low fructose 6-phosphate concentrations on phosphofructokinase (Barbehenn et al., 1974; . At the morula stage there is a tenfold rise in utilization of glucose via glycolysis (Wales, 1969) and oxidation by the tricarboxylic acid cycle (Brinster, 1967) . The citrate concentration does not fall at this stage but the concentrations of metabolites which can facilitate phosphofructokinase activity (e.g. ADP, AMP and fructose 6-phosphate) rise, probably because of increased hexokinase activity brought about either through changes in the amount of enzyme (Brinster, 1968) or by allosteric effectors (Barbehenn et a/., 1978) . In the presence of pyruvate the citrate concentration is sufficiently high for the block at phosphofructokinase to be maintained until the blastocyst stage (Barbehenn ef al., 1978).
Glucose, lactate and pyruvate are all available to the embryo in the uterus and oviduct. The initial block to glycolysis probably allows the embryo to direct the incorporation of glucose into glycogen which can then be used as an energy source when the embryo implants.
Postimplantation embryo metabolism
Implantation marks a number of major changes for the embryo and its environment. Firstly, the embryo ceases to be free within the uterine lumen; it attaches to the epithelium and then becomes surrounded by the rapidly proliferating cells of the uterine endometrium which form the decidua. Secondly, cleavage divisions are succeeded by growth: from the blastocyst at 4.5 dayspost coitum to the 25-somite stage at 9.5 days the wet weight of the mouse embryo increases 10000-fold. At the primitive-streak stage cellcycle times may be as short as 4 h (Snow, 1977) . Thirdly, extensive differentiation occurs, initially in the trophectoderm lineage followed by the primitive endoderm and finally in the embryonic lineage proper. In addition the early postimplantation period sees extensive cell movements within the embryo and the formation of the large fluid-filled cavities of the yolk sac, amnion and chorion.
Although many crucial developmental events occur in the stages between implantation and organogenesis, they have been neglected biochemically. The mouse embryo is very difficult to isolate until approx. 6 days post coitum. At this stage it is considerably larger than the blastocyst and it has proved possible to measure a range of metabolic parameters (including glucose utilization, ATP levels and enzyme activities) in single embryos from this stage onwards (Clough, 1984) . The rapid growth rate does not make it essential to normalize such parameters to protein or DNA content within the embryo as the coefficient of variation between embryos of the same age is typically about 20% (Kozak & Quinn, 1975; Clough, 1984) .
Culture experiments in tifro have shown that glucose is the only energy source required by early postimplantation rat embryos (New, 1978; Cockroft, 1979) and this is also almost certainly true of the mouse. By using short incubation times in small volumes of a defined medium Clough & Whittingham (1983) were able to measure carbon dioxide and lactate production from [U-lJC]glucose in embryos aged from 6 to 9.5 days (i.e. from 1.5 days after implantation). The pattern of glucose metabolism remains similar over this 3.5-day period and is characterized by very high rates of glycolysis (5-7nmol of lactate/mg of protein per h) comparable with those of rapidly dividing tumour cells. Under our standard conditions of 5% COz in air, over 95% of glucose uptake was accounted for by lactate production. Only a very small fraction of glucose is metabolized via the tricarboxylic acid cycle (perhaps onethousandth of that converted to lactate, judged by CO, production from [6-'JC]glucose). Oxidation of C-l is much greater (C-1 :C-6 ratios are 3.4, 19 and 25 for 6.5-, 7.5-and 8.5-day embryos respectively). The pentose phosphate shunt is thus the most active oxidative pathway, probably in order to supply ribose moieties for nucleic acid synthesis, but still only accounts for 1-2% of total glucose uptake.
When 7.5-day embryos are incubated at lower oxygen tensions, CO, production from glucose fell whilst lactate production rose. Little is known of the embryonic environment at this stage, but ultrastructural observations in the rat (Merker & Villegas, 1970) suggest that the embryo is surrounded by a poorly perfused blood-filled sinus. Oxygen availability is probably low. Thus the glycolytic rate in ciuo is probably higher, and the oxidation of glucose lower, than is found in citro.
After implantation the acti Iities of a number of glycolytic enzymes are greatly increased : hexokinase, for example, has an activity 10-50-fold higher than in preimplantation embryos. Other glycolytic enzymes (e.g phosphoglycerate kinase, lactate dehydrogenase) are first synthesized by the embryo after implantation. It seems that an important component of the metabolic transition at implantation is a wholesale change in the expression of glycolytic enzymes by theembryo. At the same time the activitiesof mitochondrial energy systems appear to be rather low (see below).
During early somitogenesis, tricarboxylic acid cycle activity increases in rat (Tanimura & Ishepard, 1970) and mouse (Clough & Whittingham, 1983) e:mbryos such that by the 25-somite stage as much as half of the ATP equivalents generated from glucose catabolism coiild be provided by this pathway. In the rat the activities of the electrontransport chain and mitochondrial ATPase (Mackler, 1970) , and in the mouse that of mitochondrial NADdependent malate dehydrogenase, increase during somitogenesis. Mitochondria adopt a more active structural configuration. It is not known what prompts these changes although oxygen availability increases during organogenesis as first the yolk sac and then the chorioallantoic circulation are established. Morriss & New (1979) have shown that raised oxygen concentrations in citro cause neural tube defects and that mitochondria are precociously differentiated in the neuroepithelium of such embryos. Oxygen concentration, then, may be important in the gradual restoration of a more typical pattern of energy metabolism during organogenesis through induction of mitochondrial functions.
Conclusion
Energy metabolism in the mouse embryo (see Fig. 1 ) is closely linked to the changing environment and physiological needs of the embryo. The mechanisms for these transitions in metabolic patterns during embryogenesis are incompletely understood, although control by pre-programmed and inducible changes in gene expression, and by modulation of enzymic activity by metabolites, are all implicated. Less is known about the embryonic environment during the crucial early postimplantation phases. Further studies of these areas are of importance because of the light they can throw on both the developmental control of metabolism and the likely effects of disturbing the normal processes of that control, or the environment itself.
al., 1982) and in far less than 1% in the offspring of normal, non-diabetic rat mothers. The obvious similarities between these skeletal malformations and those encountered in human diabetic pregnancy make further studies imperative. In the present study particular attention will be paid to the possible relationship between diabetic malformations and heredity, severity of maternal diabetes and gestational age, and trace metal disturbances.
Experimental
Diabetes was induced in female virgin Sprague Dawley rats by a single intravenous injection of streptozotocin 2-5 weeks before mating and conception (Eriksson e l id., 1980) . A manifest diabetic state was considered to be present when the blood glucose level of a streptozotocin-injected animal exceeded 20mmol/l. The manifest diabetic animals were either allowed to conceive and go through pregnancy without any type of treatment, or submitted to insulin treatment consisting of one daily subcutaneous injection of 4-8 i.u. of Novo Ultralente Insulin (Novo A/S, Copenhagen, Denmark). The insulin treatment commenced 1 week after the streptozotocin injection and 1-3 weeks before the onset of pregnancy in the insulin-treated diabetic rats. The pregnan-
